0001209191-23-015516.txt : 20230303
0001209191-23-015516.hdr.sgml : 20230303
20230303163026
ACCESSION NUMBER: 0001209191-23-015516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Konidaris Tasos
CENTRAL INDEX KEY: 0001320982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 23704588
MAIL ADDRESS:
STREET 1: 103 JFK PARKWAY
CITY: SHORT HILLS
STATE: NJ
ZIP: 07078
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001320982
Konidaris Tasos
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
Executive Vice President & CFO
Class A Common Stock
2023-03-01
4
M
0
36197
A
247832
D
Restricted Stock Units
2023-03-01
4
M
0
36197
0.00
D
Class A Common Stock
36197
72394
D
Represents shares of the Issuer's Class A Common Stock awarded to the reporting person in connection with the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
On March 1, 2021, the reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Exhibit 24-Power of Attorney
/s/ Denis Butkovic, Attorney-in-Fact
2023-03-03
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents that the undersigned, does hereby make, constitute
and appoint Denis Butkovic and Chris Daly as a true and lawful attorney-in-fact
of the undersigned with full powers of substitution and revocation, for and in
the name, place and stead of the undersigned (in the undersigned's individual
capacity), to execute and deliver such forms that the undersigned may be
required to file with the U.S. Securities and Exchange Commission as a result of
the undersigned's ownership of or transactions in securities of Amneal
Pharmaceuticals, Inc. pursuant to Sections 13(d), 13(g) and 16(a) of the
Securities Exchange Act of 1934, as amended, including without limitation,
Schedule 13D, Schedule 13G, Form 3, Form 4 and Form 5 (including any amendments
thereto). The Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Schedule 13D, Schedule 13G, Forms 3, 4
and 5 with regard to his or her ownership of or transactions in securities of
Amneal Pharmaceuticals, Inc., unless earlier revoked in writing. The undersigned
acknowledges that Denis Butkovic and Chris Daly are not assuming any of the
undersigned's responsibilities to comply with Section 13 or Section 16 of the
Securities Exchange Act of 1934, as amended.
By: /s/ Anastasios Konidaris
Name: Anastasios Konidaris
Date: February 28, 2023